The relationship between glycated hemoglobin and polymorphonuclear leukocyte leukotriene B4 release in people with diabetes mellitus

Diabetes Res Clin Pract. 1999 Oct;46(1):43-5. doi: 10.1016/s0168-8227(99)00065-0.

Abstract

In order to evaluate polymorphonuclear leukocyte (PMN) activity in diabetes mellitus, leukotriene B4 (LTB4) levels were measured in sixty patients, 31 affected with Type 1 diabetes mellitus and 29 affected with Type 2 diabetes mellitus. The LTB4 levels (12.1+/-0.2 pg/100 microl) in diabetic patients were higher compared to those of the control group (7.9+/-0.1 pg/100 microl) (P < 0.001), and remained significantly higher (P < 0.001) (12.8+/-0.2 pg/100 microl) than in the control group (11.0+/-0.2 pg/100 microl) after stimulation with calcium ionophore. A significant and positive correlation between glycated hemoglobin and LTB4 was demonstrated (P < 0.001, r = 0.80). This study demonstrates that in diabetic patients there is a PMN activation and that this activation is correlated to glycated hemoglobin level.

MeSH terms

  • Adult
  • Aged
  • Blood Glucose / metabolism
  • Calcimycin / pharmacology
  • Diabetes Mellitus, Type 1 / blood*
  • Diabetes Mellitus, Type 2 / blood*
  • Female
  • Glycated Hemoglobin / metabolism*
  • Humans
  • In Vitro Techniques
  • Leukotriene B4 / blood*
  • Male
  • Middle Aged
  • Neutrophils / drug effects
  • Neutrophils / physiology*
  • Reference Values
  • Regression Analysis

Substances

  • Blood Glucose
  • Glycated Hemoglobin A
  • Leukotriene B4
  • Calcimycin